Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-07-03

FDA Approved: CYANOKIT — Supplemental Application (BTG INTERNATIONAL INC.)

View source ↗

Summary

The FDA approved a supplemental application for Cyanokit (hydroxocobalamin) submitted by BTG International Inc. for use related to cyanide poisoning treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cyanokit (hydroxocobalamin)

Snippet

SUPPL AP for CYANOKIT (HYDROXOCOBALAMIN)